Product Information
AMLODIPINE-OLMESARTAN 5-40 MG is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.3122 per EA under NDC 31722044690. Its NADAC has been published 33 times since Jan 7, 2026.
FDA first approved this application on Feb 14, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 40 mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722044690
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA209591FDA Approved
2/14/2025
TE Code
AB
On Market Since
2/14/2025
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has been published 33 times since Jan 7, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3122 per EA |
|---|---|
| All-time high | $0.3122 (Aug 19, 2026) |
| All-time low | $0.2762 (Apr 22, 2026) |
| 52-week high | $0.3122 |
| 52-week low | $0.2762 |
| Median price | $0.2849 |
| Average price | $0.2909 |
| Largest weekly change | -5.4% (Feb 18, 2026) |
| Weeks tracked | 33 |
| Tracking since | Jan 7, 2026 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 5-40 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-40 MG, manufactured by Camber Pharmaceuticals Inc., is $0.3122 per EA (NDC 31722044690), effective Aug 19, 2026.
How has the price of AMLODIPINE-OLMESARTAN 5-40 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has held within roughly two percent of its current level. It has been tracked across 33 weekly CMS publications since Jan 7, 2026.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-40 MG?
Since Jan 7, 2026, the NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has ranged from a low of $0.2762 (Apr 22, 2026) to a high of $0.3122 (Aug 19, 2026), with a median of $0.2849 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-40 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-OLMESARTAN 5-40 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-OLMESARTAN 5-40 MG?
AMLODIPINE-OLMESARTAN 5-40 MG (NDC 31722044690) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.